Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

A Walnut-Enriched Diet Affects Gut Microbiome in Healthy Caucasian Subjects: A Randomized, Controlled Trial.

Bamberger C, Rossmeier A, Lechner K, Wu L, Waldmann E, Fischer S, Stark RG, Altenhofer J, Henze K, Parhofer KG.

Nutrients. 2018 Feb 22;10(2). pii: E244. doi: 10.3390/nu10020244.

2.

A Walnut-Enriched Diet Reduces Lipids in Healthy Caucasian Subjects, Independent of Recommended Macronutrient Replacement and Time Point of Consumption: a Prospective, Randomized, Controlled Trial.

Bamberger C, Rossmeier A, Lechner K, Wu L, Waldmann E, Stark RG, Altenhofer J, Henze K, Parhofer KG.

Nutrients. 2017 Oct 6;9(10). pii: E1097. doi: 10.3390/nu9101097.

3.

Walnut-enriched diet reduces fasting non-HDL-cholesterol and apolipoprotein B in healthy Caucasian subjects: a randomized controlled cross-over clinical trial.

Wu L, Piotrowski K, Rau T, Waldmann E, Broedl UC, Demmelmair H, Koletzko B, Stark RG, Nagel JM, Mantzoros CS, Parhofer KG.

Metabolism. 2014 Mar;63(3):382-91. doi: 10.1016/j.metabol.2013.11.005. Epub 2013 Nov 12.

4.

High-dose treatment with telmisartan induces monocytic peroxisome proliferator-activated receptor-γ target genes in patients with the metabolic syndrome.

Bähr IN, Tretter P, Krüger J, Stark RG, Schimkus J, Unger T, Kappert K, Scholze J, Parhofer KG, Kintscher U.

Hypertension. 2011 Oct;58(4):725-32. doi: 10.1161/HYPERTENSIONAHA.111.173542. Epub 2011 Aug 29.

PMID:
21876071
5.

Medical care of type 2 diabetes in German disease management programmes: a population-based evaluation.

Stark RG, Schunk MV, Meisinger C, Rathmann W, Leidl R, Holle R; KORA Study Group.

Diabetes Metab Res Rev. 2011 May;27(4):383-91. doi: 10.1002/dmrr.1186.

PMID:
21308948
6.

Health care use and costs of adverse drug events emerging from outpatient treatment in Germany: a modelling approach.

Stark RG, John J, Leidl R.

BMC Health Serv Res. 2011 Jan 13;11:9. doi: 10.1186/1472-6963-11-9.

7.

Metabolic syndrome predicts vascular changes in whole body magnetic resonance imaging in patients with long standing diabetes mellitus.

Findeisen HM, Weckbach S, Stark RG, Reiser MF, Schoenberg SO, Parhofer KG.

Cardiovasc Diabetol. 2010 Aug 30;9:44. doi: 10.1186/1475-2840-9-44.

8.

Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany.

Stark RG, Reitmeir P, Leidl R, König HH.

Inflamm Bowel Dis. 2010 Jan;16(1):42-51. doi: 10.1002/ibd.20989.

PMID:
19475674

Supplemental Content

Loading ...
Support Center